tenk.fyi

Jasper Therapeutics, Inc.

JSPRNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$75.8M

6.4% YoY

EPS

$-3.95

19.2% YoY

Cash

$28.7M

59.9% YoY

FY 2025 · As of 2025-12-31

No recent insider transactions found.

ProShowing last 90 days. Full 12+ month history available on Pro.
Upgrade